focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 337.00
Bid: 321.00
Ask: 326.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.558%)
Open: 337.00
High: 337.00
Low: 337.00
Prev. Close: 337.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

Thu, 04th Jun 2020 13:19

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Thursday and not separately reported by Alliance News:

----------

Open Orphan PLC - pharmaceutical services - Launches antibody testing service, hVIVO Covid Clear Test, following the successful completion of installation, testing and training. Test will be offered to large employer groups and channel partners including GP networks, nursing services, health clinics and private hospitals. Samples will be tested in the company's London laboratory with results returned within 48 hours.

----------

PureTech Health PLC - biotherapeutics - Founded entity Follica reports positive feedback from an end of Phase 2 meeting with the US Food & Drug Administration for its lead programme to treat male androgenetic alopecia. Follica plans to advance the programme into phase 3 development in 2020 following the successful safety and efficacy optimisation study announced in December 2019.

----------

Hutchison China Meditech Ltd - biopharmaceutical - Independent Data Monitoring Committee of the Frutiga study of fruquintinib has completed a planned interim data review and has recommended continuation of the trial. Frutiga is a phase III trial in China of fruquintinib in combination with paclitaxel in the treatment of patients with advanced gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have progressed after first-line standard chemotherapy.

----------

Oncimmune Holdings PLC - immunodiagnostics - Revenue to be in line with market expectations for year to May 31, with further strong growth expected in financial 2021. Cash at year-end expected to be GBP4.2 million and net debt of GBP3.1 million. Next 18 months expected to create substantial revenues within the EarlyCDT product business. Pipeline of contracts within the ImmunoInsights services business building. Geoffrey Hamilton-Fairley, non-executive vice chair; Julian Hirst, independent non-executive director; and Carsten Schroeder, independent non-executive director, have stepped down with immediate effect following board restructuring.

----------

Loungers PLC - bars and restaurants - Opened 17 sites for take-out and will open a further 10 sites on the same basis over the next week. Choses not to go down the delivery route. Looking to trial order-at-table technology and considering menu size. Plans to trial going cashless after re-opening. Anticipating some of sites being allowed to open in July. Expects to trade profitably with social distancing rules in place.

----------

Personal Group Holdings PLC - employee benefits - Too early to accurately assess eventual impact of Covid-19 on the company. Made an encouraging start to 2020. Switched salesforce to telesales to retain and recapture insurance policyholders. Introduced new company-wide pandemic insurance product for clients. Paying out on Covid-19 claims and supporting bereaved families and hospitalised policyholders. Negotiating significant potential new Let's Connect and Insurance clients.

----------

XP Power Ltd - power control components - All manufacturing and logistics facilities currently operational. Operational performance continuing to improve following the extended shutdown of Chinese manufacturing facility in February, and the associated supply chain challenges. Local supply chains in China and Vietnam are working at pre-Covid-19 capacity levels. Trading during April and May encouraging. Order intake in April and May continues to be strong. Sees exceptional levels of demand from its Healthcare customers. Expects this demand to normalise in second half of 2020. Revenue for five months to May-end up 7% year-on-year at GBP86.3 million. Year-to-date orders up 52% at GBP128.0 million. Net debt GBP38.0 million at May 31. Good near-term visibility due to strong order book.

----------

Randall & Quilter Investment Holdings Ltd - insurance - Completes loss portfolio transfer from Houston International Insurance Group. Agreement provides reinsurance protection and limited adverse development cover for circa USD95 million of net reserves of three companies in Houston International - Houston Specialty Insurance Co, Imperium Insurance Co and Great Midwest Insurance Co. The reserves relate to the companies' 2017 and prior policy years for certain portfolios.

----------

Clear Leisure PLC - investments - Shareholder Eufingest SA agreed to extend repayment of loans worth EUR3.9 million and GBP30,000 to September 30 or such earlier date as may be agreed with Clear Leisure.

----------

Kazera Global PLC - investment - Acquires a controlling interest in a near-term producing diamond mine and in a heavy mineral sands opportunity in South Africa. To buy a 90% stake in Deep Blue Minerals (Pty) Ltd and a stake in Whale Head Minerals (Pty) Ltd. Acquisition cost of the stake in Deep Blue Minerals is GBP600,000 funded via issue of 120 million ordinary shares at 0.5 pence each. To buy a stake in Whale Head Minerals representing 90% of its issued capital. To assume USD500,000 of liabilities from the vendor of the shares in Whale Head Minerals.

----------

Cluff Natural Resources PLC - natural resources investments - Fully committed to drilling Pensacola and Selene prospects in UK North Sea. To begin farm-out process on a further two of its licences in the second half of 2020. Applied for multiple licences in the UK 32nd offshore licensing round, with results expected this summer. In a strong financial position with cash of GBP13.2 million as at March 31. Will review opportunities, including the potential to acquire cash generative production portfolios. To seek shareholder approval to rename itself Deltic Energy PLC.

----------

Pure Gold Mining Inc - mining - Drilling restarts at PureGold Red Lake mine in Red Lake, Canada. Over 30,000 meters of diamond drilling, including both underground and surface drilling, is planned to optimize the near term mine plan, expedite the growth of our mineral resources and aggressively expand new high-grade discoveries. Over 30,000 meters of diamond drilling, including both underground and surface drilling, planned to optimize the near term mine plan, expedite the growth of our mineral resources and aggressively expand new high-grade discoveries.

----------

Hummingbird Resources PLC - gold mining - Inks earn-in agreement with ARX Resources Ltd for the company's Dugbe Gold project located in Liberia. Pact requires ARX completing a definitive feasibility study, carry out a significant exploration programme and cover all project costs over the two year earn-in period. Earn-in entitles ARX to earn up to a 49% interest in the project, and includes the payment by ARX to Hummingbird of a non-refundable deposit of USD2 million. Hummingbird secures the right to acquire an exploration licence in Liberia, which is surrounded on all sides by the company's existing mineral development agreement.

----------

Blackbird PLC - cloud video editing platform - Sports and live event production specialist Whisper has chosen Blackbird to drive major video production efficiencies for its clients, including Formula One. Whisper production team will use Blackbird's toolset to remotely edit and enrich documentaries, interviews and behind-the-scenes long form content.

----------

Codemasters Group Holdings PLC - video games - To release Project CARS 3 game in late summer 2020 for PlayStation 4 and the Xbox One family of devices.

----------

Elecosoft PLC - architectural and engineering software - Revenue for four months to April 30 down 3% year-on-year. Recurring maintenance, support and subscription revenue 6% higher. Pretax profit up 25% year-on-year. Net cash of GBP3.1 million at April 30.

----------

CyanConnode Holdings PLC - machine-to-machine communication - Substantial contract from Indian utility, Jaipur Vidyut Vitran Nigam Ltd, relating to two projects, which had been delayed, has now received the necessary approvals to resume the implementation. Further steps taken to reduce cost base amid virus disruption. Thai contract continues to meet project deliverables and payments were received from the customer at the end of March and May.

----------

Van Elle Holdings PLC - ground engineering - Appoints former Galliford Try PLC's chief financial officer Frank Nelson as a non-executive director and chair designate, replacing outgoing Adrian Barden. April trading consistent with revised assumptions, with revenue at 20% of pre Covid-19 forecast levels. Revenue for year to April 30 down 4% year-on-year at GBP85 million. To report an underlying pre-tax loss for financial 2020 due to a significant adverse impact from virus outbreak. Not appropriate to reinstate guidance for financial 2021. Customer activity levels beginning to increase. Order book at April 30 in line with the half year position at GBP31.7 million, although enquiry levels have reduced by circa 20% compared to previous levels. Cash of GBP12 million at May 31. In talks for additional debt facilities.

----------

Dillistone Group PLC - recruitment technology - Gets GBP1.5 million under UK government's coronavirus loan scheme. To use loan for working capital purposes, including development of existing and new products. Range of likely outcomes for 2020 has significantly improved. Too early to quantify the impact of the pandemic over 2020, however, the most likely outcome for first half will be a small loss.

----------

By Tapan Panchal; tapanpanchal@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
14 May 2024 14:33

Hutchmed announces trials of HMPL-306 and Surufatinib cancer therapies

(Alliance News) - Hutchmed (China) Ltd on Tuesday announced upcoming trials for two of its pipeline cancer treatments, both of which it believes could fill significant clinical gaps.

Read more
14 May 2024 11:42

Hutchmed China launches two cancer treatment trials

(Sharecast News) - Hutchmed China announced the start of two significant clinical trials on Tuesday, aimed at addressing critical unmet needs in cancer treatment.

Read more
3 May 2024 13:37

UK shareholder meetings calendar - next 7 days

Monday 6 May 
no events scheduled 
Tuesday 7 May 
Caledonia Mining Corp PLCAGM
CPPGroup PLCAGM
Just Group PLCAGM
Macfarlane Group PLC AGM
Plus500 LtdAGM
Supernova Digital Assets PLCAGM
Wednesday 8 May 
Airea PLCAGM
Antofagasta PLCAGM
Aston Martin Lagonda Global Holdings PLCAGM
Deltex Medical Group PLCAGM
Direct Line Insurance Group PLCAGM
Fidelity European Trust PLCAGM
Haleon PLCAGM
Jardine Matheson PLCAGM
JZ Capital Partners LtdEGM re investing in a secondary fund
Oscillate PLCAGM
Pershing Square Holdings LtdAGM
Rentokil Initial PLCAGM
WPP PLCAGM
Thursday 9 May 
Ascential PLCAGM
BAE Systems PLCAGM
Balfour Beatty PLCAGM
Barclays PLCAGM
CAB Payments Holdings PLCAGM
Catenai PLCGM re convertible loan note
Clarkson PLCAGM
FBD Holdings PLCAGM
Genel Energy plcAGM
Gym Group PLCAGM
Harbour Energy PLCAGM
Hiscox LtdAGM
IMI PLCAGM
Inchcape PLCAGM
Indivior PLCAGM
John Wood Group PLCAGM
Jupiter Fund Management PLCAGM
Logistics Development Group PLCAGM
Man Group PLCAGM
Morgan Advanced Materials PLCAGM
OSB Group PLCAGM
Public Policy Holding Co IncAGM
Rathbones Group PLCAGM
RM PLCAGM
Spire Healthcare Group PLCAGM
Synthomer PLCAGM
Uniphar PLCAGM
Friday 10 May 
Cairn Homes PLCAGM
Derwent London PLCAGM
Diversified Energy Co PLCAGM
Hutchmed China LtdAGM
Irish Residential Properties REIT PLCAGM
Kenmare Resources PLCAGM
Rightmove PLCAGM
Serinus Energy PLCAGM
Standard Chartered PLCAGM
Wheaton Precious Metals CorpAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
26 Apr 2024 16:09

Hutchmed notes CHMP's positive opinion for fruiquintinib approval

(Alliance News) - Hutchmed (China) Ltd on Friday said that its partner Takeda Pharmaceutical Co Ltd has been notified that the Committee for Medicinal Products for Human Use of the European Medicines Agency recommends approval for fruquintinib.

Read more
5 Apr 2024 11:54

Hutchmed China to make several presentations at cancer research meeting

(Sharecast News) - Hutchmed China announced the upcoming presentation of new and updated data from various studies featuring compounds it had discovered on Friday, at the American Association of Cancer Research (AACR) annual meeting from 5 to 10 April in San Diego, California.

Read more
2 Apr 2024 12:11

Hutchmed endometrial cancer treatment gets priority review in China

(Sharecast News) - Hutchmed China announced the acceptance and granting of priority review by the China National Medical Products Administration (NMPA) for a new drug application combining fruquintinib and sintilimab for the treatment of advanced endometrial cancer on Tuesday.

Read more
2 Apr 2024 10:32

Hutchmed endometrial cancer treatment application accepted for review

(Alliance News) - Hutchmed (China) Ltd on Tuesday jointly announced with Innovent Biologics that their new drug application for the combined fruquintinib and sintilimab treatment for endometrial cancer has been granted priority review by the China National Medical Products Administration.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
28 Mar 2024 13:02

Hutchmed cancer treatment indication accepted for review in China

(Sharecast News) - Hutchmed China announced a significant milestone in its cancer treatment work on Thursday, with the supplemental new drug application (sNDA) for savolitinib had been accepted for review by the China National Medical Products Administration (NMPA).

Read more
28 Mar 2024 11:08

Hutchmed lung cancer treatment accepted for review in China

(Alliance News) - Hutchmed (China) Ltd on Thursday said its supplemental new drug application for savolitinib has been accepted for review by the China National Medical Products Administration.

Read more
28 Mar 2024 08:08

LONDON BRIEFING: JD Sports backs outlook; Spirent accepts new offer

(Alliance News) - Stocks in London traded higher early on Thursday in the final trading day of a holiday-shortened week, despite some hawkish words from a US central banker.

Read more
22 Mar 2024 10:09

Hutchmed begins registration stage for sovleplenib phase 2/3 trial

(Alliance News) - Hutchmed (China) Ltd on Friday said it initiated the registration stage of the phase 2/3 clinical trial for sovleplenib, its warm antibody autoimmune hemolytic anemia treatment.

Read more
28 Feb 2024 17:31

EARNINGS: Hutchmed revenue surges, Craven House's loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
21 Feb 2024 15:14

UK earnings, trading statements calendar - next 7 days

Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
Friday 23 February 
City of London Investment Group PLCHalf Year Results
Irish Residential Properties REIT PLCFull Year Results
Standard Chartered PLCFull Year Results
Monday 26 February 
Base Resources LtdHalf Year Results
Bunzl PLCFull Year Results
EnSilica PLCHalf Year Results
Kosmos Energy LtdFull Year Results
Made Tech Group PLCHalf Year Results
Tristel PLCHalf Year Results
Tuesday 27 February 
abrdn Equity Income Trust PLCFull Year Results
abrdn PLCFull Year Results
Croda International PLCFull Year Results
Kitwave Group PLCFull Year Results
McBride PLCHalf Year Results
PCI-PAL PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Synectics PLCFull Year Results
Uniphar PLCFull Year Results
Unite Group PLCFull Year Results
Wednesday 28 February 
AB Dynamics PLCTrading Statement
ASA International Group PLCTrading Statement
Aston Martin Lagonda Global Holdings PLCFull Year Results
Avingtrans PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Derwent London PLCFull Year Results
Glenveagh Properties PLCFull Year Results
Grit Real Estate Income Group LtdHalf Year Results
Hutchmed China LtdFull Year Results
International Personal Finance PLCFull Year Results
Just Eat Takeaway.com NVFull Year Results
Primary Health Properties PLCFull Year Results
Reckitt Benckiser Group PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
RHI Magnesita NVFull Year Results
St James's Place PLCFull Year Results
Taylor Wimpey PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
7 Feb 2024 09:50

Hutchmed hails fruquintinib trial results for gastric cancer treatment

(Alliance News) - Hutchmed (China) Ltd on Wednesday said phase three data for fruquintinib in combination with paclitaxel showed an improvement in overall survival for patients with gastric or gastroesophageal junction adenocarcinoma.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.